Clinical Trial Update: Effect of Phenazopyridine on Prolapse Surgery Voiding Trials [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating phenazopyridine for improving voiding trials after prolapse surgery has completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Urinary Retention
• Urinary Retention

Drugs mentioned

• Phenazopyridine (phenazopyridine)

Snippet

Sponsor: University of Massachusetts, Worcester | Conditions: Urinary Retention Postoperative | Phase 3 | Status: COMPLETED | Results posted: 2019-03-26